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In amyotrophic lateral sclerosis (ALS) bulbar disease biomarkers are lacking. We evaluated a novel 
tongue electrical impedance myography (EIM) system, utilising both 2D and 3D electrode 
configurations for detection of tongue pathology. 
Methods 
Longitudinal multi-frequency phase angle spectra were recorded from 41 patients with ALS (baseline, 
3 and 6 months) and 30 healthy volunteers (baseline and 6 months). . ALS functional rating scale-
revised (ALSFRS-R) data and quantitative tongue strength measurements were collected. EIM data 
were analysed for reliability (intra-class correlation coefficient; ICC) and differences between patients 
and volunteers ascertained using both univariate (Mann-Whitney U test) and multivariate techniques 
(feature selection and L2 norm). 
Results 
The device produced highly reliable data (pooled ICC: 0.836). Significant EIM differences were 
apparent between ALS patients and healthy volunteers (P<0.001). EIM data demonstrated a significant 
relationship to tongue strength and bulbar ALSFRS-R scores (P<0.015). The EIM recordings revealed a 
group level longitudinal change over 6 months and consistently identified patients in whom symptoms 
or tongue strength changed.  
Conclusions 
The novel EIM tongue system produces reliable data and can differentiate between healthy muscle 
and ALS-related disease. 
Significance 
Tongue EIM utilising multiple frequencies and electrode configurations has potential as a bulbar 
disease biomarker in ALS. 
Highlights 
Novel electrical impedance myography system uses electrodes on both surfaces of the tongue. 
The device produces reliable data, even in inexperienced hands. 









Clinical practice and research in amyotrophic lateral sclerosis (ALS) is hampered by the limitations of 
available disease biomarkers, with bulbar biomarkers particularly scarce  (Kiernan et al. , 2011, Simon 
et al. , 2014, Benatar et al. , 2016). Bulbar-onset ALS makes up approximately 25% of the total caseload 
and nearly all patients exhibit bulbar impairment during their disease course (Haverkamp et al. , 1995). 
Impaired bulbar function significantly impacts on quality of life and is associated with a poor 
prognosis(del Aguila et al. , 2003), making new tools to identify and monitor bulbar disease highly 
desirable (Chiò et al. , 2009, Fujimura-Kiyono et al. , 2011). Despite this need there are few methods 
offering an objective measurement of bulbar disease. Quantitative tongue strength assessments have 
found reduced tongue strength in ALS (Weikamp et al. , 2012), but such tests are highly dependent on 
patient effort. The standard means of assessing ALS disease progression, the ALS functional rating 
scale-revised (ALSFRS-R), comprises a bulbar sub-score, which is subjective and may be affected by 
symptomatic interventions  (Giess et al. , 2000, Pinto et al. , 2017). Imaging modalities have shown 
promise, particularly ultrasound through detection of fasciculations (Misawa et al. , 2011).  Changes 
in tongue thickness have also been reported, with early evidence to suggest a relationship with 
functional measures (Nakamori et al. , 2016); the test is relatively easy to perform, although further 
work is required to standardise the methodology.  
Electrical impedance-based approaches, pioneered by Dr S Rutkove and termed electrical impedance 
myography (EIM), show enormous promise as a potential biomarker for ALS and other neuromuscular 
conditions (Rutkove et al. , 2014, Sanchez et al. , 2017b, Mul et al. , 2018, Shefner et al. , 2018, Kapur 
et al. , 2019). Using surface electrodes placed on a muscle of interest, low intensity alternating current 
(AC) is applied across a range of frequencies and the resulting surface voltages measured. From this, 
a transfer impedance is derived comprising resistive and reactive (capacitive) components that can 
provide information on muscle structure. For example, changes to myocyte size and fat content that 
occur after denervation alter the way current passes through and is stored by the tissue (Sanchez et 
al. , 2017a). As the amplitude of the applied AC is below the threshold for depolarisation of nerve and 
muscle, the technique is painless and non-invasive.  The approach is simple to use and has been 
applied to bulbar ALS via recordings on the tongue; however, the optimal configuration of electrodes 
and input frequencies are unknown (Shellikeri et al. , 2015, McIlduff et al. , 2016, Pacheck et al. , 2016, 
McIlduff et al. , 2017). 
The tongue has arguably the most complicated muscle fibre arrangement of any muscle in the human 
body, with fibres running in longitudinal, transverse and vertical  alignments (Gilbert et al. , 2005, 
Gaige et al. , 2007). Previous electrical impedance work in both muscle (Narayanaswami et al. , 2012, 
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Rutkove et al. , 2014, Schwartz et al. , 2016) and mucosal surfaces (Brown et al. , 2000, Murdoch et al. 
, 2013, Tidy et al. , 2013) has utilised 2D planar electrode arrays. Given the unique myoarchitecture of 
the tongue, we hypothesised that a multi-dimensional approach to recording, comprising both 3D (i.e. 
electrodes on both the superior and inferior tongue surfaces) and 2D (all electrodes on one surface) 
recording arrangements would be needed to provide a sensitive assessment of disease status. In order 
to test this, we developed a novel EIM device capable of multi-dimensional electrode configurations. 
We assessed the reliability of the device, its ability to detect ALS tongue pathology and disease 
progression, and the correlation to symptom questionnaire scores and tongue strength. 
 
2. Methods 
2.1 Participant recruitment 
We recruited patients with a diagnosis of ALS from the Sheffield ALS clinic between 2015 and 2018. 
All patients were required to meet the minimum diagnostic category of  the Awaji-Shima criteria for 
ALS (de Carvalho et al. , 2008). We included both patients with and without clinical and/or EMG (via 
the Awaji-Shima criteria) evidence of lower motor neurone (LMN) bulbar dysfunction.  Healthy 
volunteers with no history of neurological illness were recruited. Exclusion criteria for both groups 
included a history of oral malignancy, previous tongue biopsy, concurrent oral ulceration/infection, 
and active implanted electrical medical devices such as pacemakers, vagal nerve stimulators, and 
diaphragmatic pacing devices. Informed consent was obtained from all participants and the study was 
approved by a local research ethics committee (reference 15/YH/0121).  
2.2 Probe design 
A bespoke, handheld bioimpedance device was designed and constructed specifically for use on the 
tongue (figure 1). At the tip of the tweezer-like design a stop prevented undue compression of the 
tongue and defined the inter-electrode plate distance (figure 1). Four gold electrodes arranged in a 
square with an inter-electrode distance of 5 mm on both the upper and lower electrode plates. The 
plate separation distance was 7 mm, which was arrived at through the testing of 3D printed models 
on the participants of the study, assessing for comfort and electrode plate contact. Development was 
undertaken by TJH and JJPA. The physical compliance of the tongue muscle enables the instrument to 
investigate a fixed volume of tissue, reducing possible sources of inter-subject variation. Eight 
electrode configurations were chosen in order to study tissue in both 2-dimensional and 3-
dimensional arrangements (figure 1). A further four were initially utilised but dropped from analysis 
as recordings were not reproducible (supplementary figure 1). A sub-sensory threshold sinusoidal 
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current of 5 µA root mean square was injected across 14 frequencies, starting at 76 Hz and then 
doubling with each step increase, to a maximum of 625000 Hz.  
 
 
2.3 EIM recording procedure 
Recordings were performed with the participants sitting upright and the probe placed centrally on the 
tongue. Recording time was 10 – 20 seconds. At completion of the recording, the real and imaginary 
components of bioimpedance for each electrode configuration were visually inspected on custom 
written software. If unusable data were observed on inspection of the spectra due to, for example, 
patient movement during recording, the recording was re-attempted, providing the patient was happy 
to proceed. In contrast to previous studies (Shellikeri et al. , 2015), initial recordings of satisfactory 
quality were not discarded. Each recording session included 2 separate measurements, made 5-10 
minutes apart. EIM recordings were undertaken initially by JJPA (a consultant clinical 
neurophysiologist, total recordings = 185). Approximately 6 months into the study JJPA was joined in 
recording by SJF and, subsequently, HEM (medical students, 35 and 55 recordings, respectively), 
neither of whom had any prior experience of ALS patients, clinical research or electrophysiological 
recordings. Their training consisted of watching JJPA complete one recording and brief instruction on 
the recognition of poor-quality data (e.g. negative real part, see below). They then performed 
examinations unsupervised and all their data were included in the analysis. Patient participants 
underwent recordings every 3 months for 6 months, healthy volunteers underwent two recordings at 
baseline and 6 months. Before and after each recording the re-usable probe was cleaned using the 
Tristel Wipes, a system used in clinical environments for flexible endoscopes and ultrasound probes. 
2.4 Non-impedance data capture 
Clinical examination was documented by an experienced clinician (JJPA, PJS or CJM). ALSFRS-R data 
were collected, as were the results of the most recent EMG. Following EIM recordings, evaluation of 
tongue strength was undertaken with quantitative muscle testing (QMT) system (Averil Medical), 
coupled to the Iowa Oral Performance Instrument (IOPI)(Easterling et al. , 2013, Shellikeri et al. , 2015). 
Participants were asked to maximally push the small rubber balloon of the IOPI against their hard 
palate for 10 seconds, with the maximum force recorded (Newtons, N). Two trials were conducted 
with a short rest period between measurements; the trial with the highest recorded value was used 
for analysis. 
2.5 Statistical analyses 
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Following data download, real and imaginary components of complex impedance were exported and 
phase angle (PhA =  arctan2(X, R), and magnitude |𝑍| = √𝑅2 + 𝑋2 calculated by custom software. 
These data were then analysed using either IBM SPSS statistics (version 24), GraphPad (version 8), or 
custom code in Python. Prior to analyses, any recordings comprising negative resistivity (real part) 
values at any frequency were excluded (this likely indicates poor electrode contact). Thus, a single 
negative value at any frequency resulted in all data for that spectra being excluded. A Root Mean 
Squared Standard Deviation-based outlier detection algorithm was then used to remove spurious 
data, e.g. due to movement (see supplementary methods). As two recordings were available for 
analysis, if an initial recording was removed by the post hoc quality control, the second was used in its 
place. If both runs were available, the first was used as default. If no data were available, then that 
electrode configuration (for that particular recording) was excluded from the analysis, in keeping with 
previous studies (Shefner et al. , 2018). Data imputation was not used. As our impedance data are 
non-normally distributed, univariate comparisons of phase angle between patients and volunteers 
were undertaken with Mann-Whitney U testing, using the Benjamini-Hochberg false discovery rate 
(FDR) correction for multiple comparisons (Q-value of 0.05). Analysis of group demographics were 
undertaken using t-tests and Fisher’s exact test, as appropriate. Intra-class correlation coefficient (ICC) 
analysis was undertaken using a single measure, two-way random effects model. Presented reference 
lines correspond to guidance for determining ICC performance (Cicchetti, 1994): Poor <0.4; Fair 0.4-
0.59; Good 0.6-0.74; Excellent 0.75+. 
Multivariate analyses were undertaken using custom code written in Python (see supplementary 
methods). Robust scaling was used in order to standardise the contributions of data from each input 
frequency. The spectral features most useful in both identifying disease (by comparing patients and 
volunteers) and in detecting longitudinal change (by comparing baseline and 6-month data) were 
identified using a wrapper algorithm with an exhaustive search approach (Guyon et al. , 2003) and 3-
nearest neighbour and 4-fold cross-validation (supplementary methods). Pareto ranking was 
subsequently undertaken to identify the best feature (input frequency) combination. In order to 
assess the performance of individual electrode configurations, sensitivity, specificity and the area 
under the receiver operating curve (AUROC) were calculated.  
To facilitate exploration of the relationship between tongue EIM and bulbar symptoms/tongue 
strength, and longitudinal EIM analysis, we reduced the features identified in the wrapper analyses to 
a single value, the L2 norm (supplementary methods). This is a commonly applied mathematical 
function useful for normalising observations and represents the distance of the vector coordinate 
from the origin of the vector space. It was calculated for each electrode configuration and applied to 
symptom/strength correlation using Pearson correlation, as it is normally distributed. P values were 
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corrected for multiple comparisons using the Benjamini-Hochberg false discovery rate (FDR) 
correction. 
For longitudinal EIM analysis in the patient group (baseline, 3 months, 6 months) the L2 norm for each 
electrode configuration, ALSFRS-R bulbar subscore and tongue strength data were first normalised to 
the baseline visit.  Percentage change over time for EIM data, ALSFRS-R bulbar subscore and tongue 
strength were analysed with a mixed model using a compound symmetry covariance matrix, fitted 
using Restricted Maximum Likelihood and a Geisser-Greenhouse correction. Tukey’s correction for 
multiple comparisons was used. For healthy volunteers, 2 visits (baseline and 6 months) were 
available, this analysis was performed using paired t-tests. The standardised response mean (SRM; 
mean of paired scores change over time/standard deviation of the measured change), was used to 
assess outcome responsiveness between baseline and 6-month time-points. Longitudinal change at 
an individual patient level was assessed by using the maximum healthy volunteer L2 norm as a 





3.1 Clinical characteristics of the study subjects 
41 ALS patients (22 men, 19 women; mean age 62) and 30 healthy volunteers (14 men, 16 women; 
mean age 56) were recruited (figure 2). At baseline, 3 patients were unable to perform the EIM 
recordings: 2 had advanced/end-stage disease and complete tongue paresis, 1 was unable to tolerate 
removal of intermittent ventilatory support for enough time to allow recording. All volunteers were 
able to undertake the recordings successfully. The groups were matched for age and gender (table 1). 
17 patients had bulbar-onset disease, 24 had limb-onset disease. Median disease duration was 24 
months (range 5 to 204). At the time of recruitment, the Awaji-Shima diagnostic criteria classified 10 
patients as definite, 17 as probable, and 14 as possible. At the end of the 6-month follow up period all 
participants continued to have a clinical diagnosis of ALS. A total of 30 patients were determined to 
have clinical evidence of LMN bulbar disease at their baseline visit, as judged by the presence of 
tongue wasting, fasciculations or EMG abnormalities fulfilling the Awaji-Shima criteria. The average 
ALSFRS-R bulbar sub-score at the time of recruitment was 8. Average tongue strength was significantly 


























Site of disease onset, n (%) Limb: 24 (59%) 
Bulbar: 17 (41%) 
  











Clinical examination, n (%): 
      Dysarthria 
      Tongue atrophy 
      Tongue fasciculations 







Clinical evidence of LMN tongue 




Mean total ALSFRS-R score (range) 31  
(4-45) 
  
Mean bulbar ALSFRS-R sub-score 8  
(0-12) 
  







Table 1. Demographic, clinical, electrophysiological and tongue strength characteristics. 
 
3.2 Reliability of EIM recordings 
Intra-class correlation coefficients (ICCs) were calculated across participant groups, examiners, and 
electrode configurations. Using all available recordings, the overall ICC was 0.836, with both 3D and 
2D electrode configurations demonstrating similar test-retest reliability (ICC: 0.86 and 0.81, 
respectively; figure 3). The patient group demonstrated a slightly better performance (ICC: 0.885, vs. 
ICC: 0.788 for healthy volunteers). Test-retest reliability was consistent across visits in both groups 
(baseline patient ICC: 0.877, 3-month patient ICC: 0.855, 6-month patient ICC: 0.896; baseline healthy 
volunteer ICC: 0.774, 6-month healthy volunteer ICC: 0.805). The inter-rater ICC was 0.788, with intra-
rater reliability slightly higher at 0.854. The experience of the examiner in clinical research and 
neurophysiological recordings did not appear to impact on reliability, with both experienced and 
inexperienced examiners achieving similar ICC values (figure 3). To complement the ICC analysis, 
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coefficient of variation was calculated, and Bland-Altman plots were constructed, the latter 
demonstrating high agreement and a mean difference (indicating the estimation of systemic bias in 
the recordings) near zero (supplementary table 1 and supplementary figure 2). 
 
3.3 Comparison of EIM between ALS patients and healthy volunteers 
Comparison of ALS patients and healthy volunteers at baseline revealed significant differences across 
all electrode configurations and at multiple frequencies, with a clear trend towards improved 
discrimination at the higher frequency range (figure 4; a phase angle plot for each electrode 
configuration can be found in supplemental figure 3). To further evaluate the performance of different 
electrode configurations, frequency-based feature selection was performed using the wrapper 
algorithm, followed by pareto ranking to identify the best frequency combination for each electrode 
configuration. The performance of each configuration is shown using AUROC, sensitivity and specificity 
(figure 4; individual ROCs with 95% confidence intervals shown in supplementary figure 4). A strong 
discrimination performance was seen across both 2D and 3D electrode configurations with the top 
performing arrangements being 3D.  
 
3.4 Relationship of tongue EIM to bulbar symptoms and tongue strength 
For each electrode configuration, the correlation of the EIM data to the ALSFRS-R bulbar subscore and 
tongue strength was assessed (figure 5 and table 2). A significant linear correlation between tongue 
EIM and bulbar ALSFRS-R sub-score was observed in three of the four 3D electrode configurations and 
two of the four 2D arrangements. Similar data were also obtained for each of the ALSFRS-R subscore 
components (supplemental figure 5 and supplemental table 2). A significant linear correlation was 
also observed for tongue strength (figure 5 and table 2). A potential relationship between EIM data 
and age was also examined using healthy volunteer data and the L2 norm (supplemental figure 5). A 
comparison of EIM data in healthy volunteers aged <55 and ≥55 years also failed to indicate any 











r P r P 
3D:1  -0.133 0.361 -0.068 0.653 
3D:2  -0.519 0.000 -0.397 0.004 
3D:3  -0.313 0.014 -0.342 0.008 
3D: 4  -0.526 0.000 -0.454 0.000 
 
2D: 1 -0.175 0.163 -0.037 0.770 
2D: 2 -0.464 0.000 -0.403 0.001 
2D:3 -0.075 0.654 -0.202 0.224 
2D:4 0.434 0.003 -0.044 0.077 
Table 2. Summary table for the correlation analyses between EIM data (using the L2 norm) and 
bulbar symptoms/tongue strength for all electrode configurations. The values meeting the FDR-
adjusted P value (P= 0.014) are show in bold/shaded. 
 
   
3.5 Longitudinal changes 
We first undertook a group level analysis to ascertain the change over time relative to the baseline 
visit by taking an average of all the electrode configuration data.  We found a significant change in EIM 
phase angle at a group level in the patients (figure 6; P=0.04 between month 0 and month 3, 95% 
confidence interval = -70.75 to -0.13 and P=0.002 between month 0 and month 6, 95% confidence 
interval -149.9 to -10.64) but not in healthy volunteers (P=0.14, 95% confidence interval = -3.63 to 
24.33). No significant change occurred in the ALSFRS-R bulbar subscore over the 6-month study 
timeframe (p=0.16). Tongue strength in patients demonstrated a non-significant group level reduction 
(P=0.05), there was no change in healthy volunteers (P=0.7).  
We next explored the utility of the tongue EIM system in identifying change at an individual patient 
level (figure 6 D &E). Using the maximum change in the volunteer group as the threshold for disease-
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related progression, the EIM data consistently identified patients displaying marked deterioration in 
bulbar symptoms or tongue strength (table 3). One patient with a 4-point change in bulbar ALS-FRS 
was not identified in this analysis; however, this patient had deteriorated to the point that EIM 
recording was not possible. 
  
 14 
Patient ALSFRS-R bulbar 
subscore change 
% change in tongue strength  % change in L2 norm 
1 -1 +12 77.9 
3 +1 -38 82.7 
6 -1 -33 15.6 
8 -1 -13 71.9 
16 +2 -43 33 
19 +2 -13 203 
20 +1 -13 19 
21 -5 -51 195.4 
24 -1 -58 304 
30 -2 -5 26.6 
31 -1 -9 28.5 
32 -3 -36 23.6 
36 -4 -45 123.7 
39 -2 -76 213.2 
Patients not identified with 
≥2 point change in ALSFRS-R 
Patients not identified with 
≥10% tongue strength drop 
 
n=1 (-4; severe tongue 
atrophy/paresis prevented 
EIS recording) 
n=4 (changes: -14%, 
 -15%, -24%, -25%) 







In this study we have successfully tested a novel EIM system for evaluation of tongue muscle in ALS. 
The results show that our device is reliable, even in inexperienced hands, and highly sensitive in 
detecting ALS-related tongue pathology. The ease of recording makes the system suitable for further 
investigation. 
Our data suggest that interrogation of muscle in multiple tissue planes holds promise as means to 
maximise the utility of EIM. Despite a heterogenous patient group the EIM data could distinguish 
between patients and healthy volunteers. The pioneering work of the Rutkove group has shown the 
immense potential of EIM as a biomarker in ALS (Vucic et al. , 2018). So far, these studies have utilised 
2D electrode configurations in which all electrodes are on the same surface, with some studies 
rotating electrodes, or using arrays which permit the flow of current in more than one direction 
(Garmirian et al. , 2009, Shefner et al. , 2018). Notwithstanding such differences, as well as variations 
in electrode size and composition, the studies of the Rutkove group also found differences in tongue 
EIM in ALS compared to healthy volunteers which, like the data we present here, varied with frequency 
(McIlduff et al. , 2016, McIlduff et al. , 2017). 
 The complexity of the tongue blade myoarchitecture necessitates our multi-dimensional approach as 
a uniform pathological change throughout the muscle and across all patients seems unlikely. In 
keeping with this, limb biopsy specimens often reveal small groups of atrophic muscle fibres 
distributed heterogeneously across different samples (Baloh et al. , 2007, Al-Sarraj et al. , 2014, Jokela 
et al. , 2016). We are only aware of tongue biopsy in ALS following development of macroglossia 
(McKee et al. , 2013), but it is not uncommon to have to manipulate the EMG needle during 
examination of the tongue (and other muscles) in order to find abnormalities. While 3D electrode 
configurations outperformed 2D arrangements in disease identification and symptom/strength 
correlation, it seems rational that multiple electrode configurations, exploring different 
regions/planes of tissue are required to maximise the potential of the technique.   
We chose to examine phase angle, reported as the most disease-sensitive parameter (Rutkove et al. , 
2007) and the focus of most recent studies (e.g. (Shefner et al. , 2018)).  As a ratio of resistance and 
reactance, it is more resilient to the potentially confounding effects of tissue volume (Rutkove et al. , 
2007, Rutkove et al. , 2016). Our device provides a fixed volume of tissue between the electrodes and 
utilised a small distance between electrodes. The modelling work of Pacheck et al., indicates tongue 
volume has little impact on impedance data and we were recording in the midline of the tongue blade 
and hence not near the muscle edge. (Pacheck et al. , 2016). We therefore consider that it is unlikely 
that our results are explained by differences in tongue volume.  
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It is theoretically possible that differences in saliva could impact on the mucosa-electrode interface 
e.g. due to saliva pooling. While we did observe a significant linear relationship between EIM data and 
the ALSFRS-R saliva subscore, similar results were observed for the other components (supplementary 
figure 4) and there was a high correlation between the saliva score and the bulbar subscore total (r2 = 
0.625; data not shown). Furthermore, studies on the effects of conductive fluid on tissue impedance 
measurements indicate that if the fluid film is thin and the resistivity of the tissue is less than 100 
times the resistivity of the fluid (if higher it may act as a short-circuit), then the effect is minimal 
(Finkelstein et al. , 1984, Jones et al. , 2001). Our system was constructed with electrode faces polished 
flat in order to ensure saliva film thickness was <10µm and almost all measurements (~99%) were 
within the resistivity limit. Any potential effect will also be reduced by using a tetrapolar measurement 
approach. 
Impedance spectra produce a high dimensional dataset for the interrogation of muscle health. 
Consequently, we used a machine learning approach to select the most relevant information and 
reduce the dimensionality of the results. Previous approaches to impedance data analysis have 
included focusing on one (Tarulli et al. , 2009) or two (Roy et al. , 2019) input frequencies, ratios of 
two frequencies (Schwartz et al. , 2015), or the slope between two ratios (Rutkove et al. , 2017). Less 
frequently, machine learning, in conjunction with other clinical parameters (Srivastava et al. , 2012), 
or in combination with mixed models (Kapur et al. , 2019), has been used. Here, we employed a data 
driven approach to identify and utilise key spectral features. While previous reports have found that 
different frequencies may be useful for different muscles (McIlduff et al. , 2017), we took this a stage 
further and found that, interestingly, different features were selected for different tasks, e.g. 
patient/volunteer classification and disease related change. In our analyses we chose a feature 
selection approach in order to both maintain the original data projection and remove redundant data. 
The wrapper approach used is computationally expensive, but has the advantage of optimising 
classifier performance through examining learning results (Hsu et al. , 2011). There are, however, a 
range of other machine learning techniques that could be trialled. Once optimised the analysis can be 
streamlined, with the potential for real-time, bedside results.      
Both univariate and multivariate analyses identified mid-to-high range input frequencies as most 
discriminatory (figure 4). The majority of our patients had clinically evident disease in which one might 
expect the underlying ultrastructure of the tongue to demonstrate grouped atrophy  (Baloh et al. , 
2007, Al-Sarraj et al. , 2014). We would therefore anticipate patient/healthy differences in EIM phase 
angle to manifest at frequencies in which the current crosses the capacitance of the sarcolemma, 
which was indeed the case. Some recent studies have indicated that EIM may be able to detect muscle 
changes secondary to UMN dysfunction (Li et al. , 2017, Zong et al. , 2018). While a mixed UMN/LMN 
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dysarthria is the most common pattern encountered in ALS (Aronson et al. , 1992), it remains to be 
determined if dual pathology can be separated or quantified, either in the tongue or limb muscles. 
Our study population had a relatively broad mix of patient phenotypes. At a group level we saw little 
change in bulbar symptoms/tongue strength over the 6-month period, possibly due to the attrition of 
patients with the most pronounced disease progression. We also included several patients with 
atypical disease durations of up to 204 months; such patients are now included in many trials and are 
found in all specialist ALS clinics. A greater understanding of the potential of the device would come 
from larger numbers of patients, particularly those with no overt clinical signs of bulbar disease who 
go on to develop such symptoms.. Despite the challenges inherent in monitoring ALS patients, our 
simple change metric detected a change in the patient group over time.We were also able to identify 
change at an individual patient level, consistently identifying patients with symptom progression/loss 
of tongue strength. This suggests that the machine learning approach was capturing clinically relevant 
phenomena, although we acknowledge that our data represent only a first step in ascertaining the 
utility of this.   
A further limitation is the lack of an ALS-mimic group. While we have previously shown that bulbar 
EMG abnormalities are highly specific to ALS (Jenkins et al. , 2016), evaluation of the present device in 
patients with conditions such as spinobulbar muscular atrophy would provide insight into whether 
tongue impedance measurements are specific to ALS. In limb muscles early results suggest that 
impedance have limited efficacy in distinguishing ALS from mimic conditions (Sanchez et al. , 2017b). 
An additional limitation, not yet addressed in EIM studies, is the effect of fasciculations. In theory, 
florid, repetitive fasciculations that disrupt electrode contact could pose difficulties, but we are not 
aware of any studies examining this. Studies on the effect of muscle contractions on impedance 
recording have shown changes in various parameters, which have been argued to reflect physiological, 
rather than morphological effects (Shiffman et al. , 2003, Li et al. , 2016). Whether similar changes 
occur when muscle activity is limited to the level of the motor unit is unknown. 
Our work provides evidence that our EIM probe can be rapidly applied to ALS patients. We adopted 
an approach advocated recently for its similarity to typical clinical trials – brief instruction, then 
independent recordings (Geisbush et al. , 2015, McIlduff et al. , 2016). We included two inexperienced 
examiners, both of whom achieved test-retest reliability on par with that of a more experienced rater. 
ICC results were similar to those reported for other EIM devices (e.g. (McIlduff et al. , 2016)) and 
coefficient of variation results comparable to those reported for other neurophysiological techniques 
such as the motor unit number/size indices (Neuwirth et al. , 2016, Alix et al. , 2019).  
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A small number of patients were not able to perform the recordings due to end-stage bulbar disease 
or respiratory difficulties. Identifying bulbar pathology in end-stage disease is not a significant issue 
and monitoring such advanced disease may only reveal a plateau. At the time of recruitment, the 
patient with respiratory failure did not have access to nasal non-invasive positive pressure ventilation, 
which may have facilitated recording. In contrast to previous studies we experienced no difficulties 
with eliciting a gag reflex (Shellikeri et al. , 2015), most likely as our device does not need placement 
along a large portion of the tongue. 
In conclusion, we present a novel EIM device that produces reliable data which can be used to identify 
tongue muscle pathology in ALS. It is easy to use and is well tolerated. Our work illustrates the 





Figure 1. The novel EIM device. 
(A). The novel EIM device with 4 electrodes on the upper and lower arms. The vertical bars provide 
the compression width. 
(B). The electrode configurations used, separated into 3D and 2D groups, utilising the key employed 
in (A).  
(C). Example of the recording in an ALS patient (consent provided).  
 
Figure 2. Flow chart of the study. 
 
Figure 3. Reproducibility assessments for patients, volunteers and different examiners. 
ICC plots, including 95% confidence intervals, of 3D and 2D electrode configurations (A), patients and 
volunteers (B) and comparison of ICC at baseline and 6 months in both participant groups (C). Inter- 
and intra-rater analyses (D) and comparisons of different examiner combinations (E, F) were also 
undertaken.  
 
Figure 4. Differences in the phase angle data of patients and healthy volunteers. 
(A). Median phase angle (+95% confidence interval) for the 3D:2 electrode configuration for both 
patients and healthy volunteers.  
(B). Summary of differences between patients and healthy volunteers at baseline using a Mann-
Whitney U test and FDR correction (target P value for significance P<0.02). Values represent P values, 
shaded boxes denote significance following the FDR correction. 
(C). Summary of performance of the wrapper algorithm using AUROC, sensitivity and specificity. A 
particularly high performance was apparent for 3D electrode configurations. 
 
Figure 5. Relationship of EIM data to bulbar symptoms and tongue strength in ALS patients. 
(A-B). Scatter plots of the L2 norm and the ALSFRS-R bulbar subscore (A) and tongue strength (B) for 
the electrode configuration 3D:4. 
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(C-D). Scatter plots of the L2 norm and the ALSFRS-R bulbar subscore (A) and tongue strength (B) for 
the electrode configuration 2D:2. 
 
Figure 6. Change over time in EIM, bulbar ALSFRS-R and tongue strength. 
(A). Change over time in the L2 norm for both patients and healthy volunteers (mixed model, 
significant difference between baseline and month 6). The standardised response mean, calculated 
using the patient data, is shown.  
(B). Change in bulbar ALSFRS-R subscore over time. No significant change was seen (mixed model), the 
associated SRM is shown. 
(C). Change in tongue strength over time. No significant change was seen (mixed model), the 
associated SRM is shown. 
 (D & E). L2 norm for the absolute differences in phase angle for patients and volunteers across 3D (D) 
and 2D (E) electrode configurations. The shaded box denotes the threshold for accepting change in 




Supplementary figure 1. Additional 3D electrode configurations tested. 
(A). Summary of four additional electrode configurations tested during the study. These comprised an 
additional 3D group, with current and voltage electrodes on opposing surface of the tongue. 
(B). Intra-class correlation coefficient plot demonstrating poor performance of this group. Due to the 
lack of reliable data it was excluded from the main analysis. 
 
Supplementary figure 2. Bland-Altman plots and data. 
(A-B). Bland-Altman plots for patients and healthy volunteers. 
(C). Summary table. 
 
Supplementary figure 3. Median phase angle spectra for all electrode configurations. 
 
Supplemental figure 4. ROC curves for each electrode configuration and selected features. 
ROC curves for each electrode configuration using the features (input frequencies) selected through 
the exhaustive wrapper algorithm and pareto ranking. 4-fold cross validation was undertaken and the 
results for each fold are shown, together with the mean and 95% confidence interval. 
 
Supplementary figure 5. Relationship of EIM data to ALSFRS-R bulbar subscore components. 
(A-C). Scatter plots of the L2 norm and the ALSFRS-R bulbar subscore components for the electrode 
configuration 3D:4. 
(D-F). Scatter plots of the L2 norm and the ALSFRS-R bulbar subscore components for the electrode 
configuration 2D:2. 
FDR-adjusted p-value = 0.014. 
 
Supplementary figure 6. Effect of age. 
(A). Scatter plot of L2 norm and age for healthy volunteers. 
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(B). Summary of differences between healthy volunteers aged <55 years and ≥55 years. using a Mann-






Supplementary table 1. Coefficient of variation for the different participant groups, electrode 
configurations and examiners. 
 
Supplementary table 2. Summary table for correlation analyses between EIM data (L2 norm) and 
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